drugset / Trial / NCT02604368
A Sickle CEll Disease ComplicatioN Trial
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of this study is to assess the efficacy of SC411 in reducing the number of sickle cell crisis (SCC) events in sickle cell disease (SCD) subjects receiving SC411 compared to those subjects receiving placebo.
Timeline
- Start
- 2019-03
- Primary completion
- 2020-12
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DOCONEXENT | Other / unclassified | — | Oral |